🔎 Trials Near Me

Home › Cancer (all types) › Nevada › Reno

Cancer (all types) clinical trials in Reno, NV

7 studies for Cancer (all types) are looking for participants at sites in and around Reno (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

RecruitingPhase 2/3
  • Renown Health Medical Oncology, Reno
  • Renown Office of Clinical Research, Reno
  • Renown Regional Medical Center, Reno
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

RecruitingPhase 3
  • Research Site, Reno
Ages 18 to 130 · All sexes · Updated Sep 8, 2026 · NCT07647328

Project: Every Child for Younger Patients With Cancer

RecruitingObservational study
  • Renown Regional Medical Center, Reno
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

RecruitingObservational study
  • Cancer Care Specialists - Reno, Reno
Ages 18 to 99 · All sexes · Updated Feb 24, 2026 · NCT06207032

GEMINI-NSCLC: NSCLC Biomarker Study

RecruitingObservational study
  • Cancer Care Specialists Reno, Reno
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT05236114

Prospective Study of oncRNA Stratification of Cancer by Size and Stage

RecruitingObservational studyHealthy volunteers welcome
  • Renown Health, Reno
Ages 18 and older · All sexes · Updated Mar 18, 2025 · NCT05833360

About Cancer (all types)

If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.

More about Cancer (all types) on MedlinePlus

Cancer (all types) trials in other cities

Other studies in Reno

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.